On Wednesday, a woman was reported dead after she was introduced to the AstraZeneca vaccine. However, The Pharmacy and Poisons Board has denied that the Kenyan vaccinated with the Vaccine died of post-jab complications.
The Pharmacy and Poisons Board also reiterated that out of the 279 reported cases, 272 had mild effects which resolved within a short period.
While the Board has reported Seven serious adverse effects following Immunisation, it has called upon the public to report any deaths associated with the AstraZeneca vaccine amidst the high uptake of Vaccines in Nakuru (at 7 percent) and Uasin Gishu (at six percent).
As of April 7th, 339,893 residents had received the AstraZeneca jab and 228 have been exposed to the Sputnik V vaccine.
Therefore, do you think it was misreporting by the PPB or it's a cover up? Leave a comment, Let's keep the discussion going.
Remember to share, like, and follow for more entertainment news and social insights.
Content created and supplied by: Kaufman-TV (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More